Transmembrane TNF-α Promotes Suppressive Activities of Myeloid-Derived Suppressor Cells via TNFR2

被引:135
|
作者
Hu, Xin [1 ]
Li, Baihua [1 ]
Li, Xiaoyan [1 ]
Zhao, Xianxian [1 ]
Wan, Lin [1 ]
Lin, Guohong [1 ]
Yu, Min [1 ]
Wang, Jing [1 ]
Jiang, Xiaodan [1 ]
Feng, Wei [1 ]
Qin, Zhihai [2 ]
Yin, Bingjiao [1 ]
Li, Zhuoya [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430030, Peoples R China
[2] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100730, Peoples R China
基金
中国国家自然科学基金;
关键词
TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; IMMUNE-RESPONSE; T-CELLS; INFLAMMATION; ACTIVATION; EXPRESSION; GROWTH; DIFFERENTIATION; ACCUMULATION;
D O I
10.4049/jimmunol.1203195
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It has been reported that TNFR2 is involved in regulatory T cell induction and myeloid-derived suppressor cell (MDSC) accumulation, two kinds of immunosuppressive cells contributing to tumor immune evasion. Because transmembrane TNF-alpha (tmTNF-alpha) is the primary ligand for TNFR2, we hypothesized that tmTNF-alpha is mainly responsible for the activation of MDSCs. Indeed, we found that tmTNF-alpha, rather than secretory TNF-alpha (sTNF-alpha), activated MDSCs with enhanced suppressive activities, including upregulating arginase-1 and inducible NO synthase transcription, promoting secretion of NO, reactive oxygen species, IL-10, and TGF-beta, and enhancing inhibition of lymphocyte proliferation. This effect of tmTNF-alpha was mediated by TNFR2, as TNFR2 deficiency significantly impaired tmTNF-alpha-induced release of IL-10 and NO and inhibition of T cell proliferation by MDSC supernatant. Furthermore, tmTNF-alpha caused p38 phosphorylation and NF-kappa B activation, whereas inhibition of NF-kappa B or p38 with an inhibitor pyrrolidine dithiocarbamate or SB203580 abrogated tmTNF-alpha-mediated increased suppression of lymphocyte proliferation by MDSCs. Consistently, our in vivo study showed that ectopic expression of uncleavable tmTNF-alpha mutant by 4T1 cells significantly promoted tumor progression and angiogenesis, accompanied with more accumulation of MDSCs and regulatory T cells in the tumor site, increased production of NO, IL-10, and TGF-beta, as well as poor lymphocyte infiltration. In contrast, enforced expression of sTNF-a mutant by 4T1 cells that only released sTNF-alpha without expression of surface tmTNF-alpha markedly reduced MDSC accumulation and induced more lymphocyte infiltration instead, showing obvious tumor regression. Our data suggest that tmTNF-alpha acts as a potent activator of MDSCs via TNFR2 and reveals another novel immunosuppressive effect of this membrane molecule that promotes tumor immune escape.
引用
收藏
页码:1320 / 1331
页数:12
相关论文
共 50 条
  • [21] HMGB1 Enhances Immune Suppression by Facilitating the Differentiation and Suppressive Activity of Myeloid-Derived Suppressor Cells
    Parker, Katherine H.
    Sinha, Pratima
    Horn, Lucas A.
    Clements, Virginia K.
    Yang, Huan
    Li, Jianhua
    Tracey, Kevin J.
    Ostrand-Rosenberg, Suzanne
    CANCER RESEARCH, 2014, 74 (20) : 5723 - 5733
  • [22] Lnc-C/EBPβ Negatively Regulates the Suppressive Function of Myeloid-Derived Suppressor Cells
    Gao, Yunhuan
    Sun, Wei
    Shang, Wencong
    Li, Yuanyuan
    Zhang, Dan
    Wang, Tianze
    Zhang, Xipeng
    Zhang, Shiwu
    Zhang, Yuan
    Yang, Rongcun
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (11) : 1352 - 1363
  • [23] Low-dose TNF-α promotes angiogenesis of oral squamous cell carcinoma cells via TNFR2/Akt/mTOR axis
    Li, Shutong
    Liu, Wenchuan
    Liu, Junze
    Yang, Zongcheng
    Zhang, Liguo
    Nie, Fujiao
    Yang, Pishan
    Guo, Hongmei
    Yang, Chengzhe
    ORAL DISEASES, 2024, 30 (05) : 3004 - 3017
  • [24] Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies
    Shou, Dawei
    Wen, Liang
    Song, Zhenya
    Yin, Jian
    Sun, Qiming
    Gong, Weihua
    ONCOTARGET, 2016, 7 (39) : 64505 - 64511
  • [25] Acitretin Promotes the Differentiation of Myeloid-Derived Suppressor Cells in the Treatment of Psoriasis
    Liu, Panpan
    Peng, Cong
    Chen, Xiang
    Wu, Lisha
    Yin, Mingzhu
    Li, Jie
    Qin, Qunshi
    Kuang, Yehong
    Zhu, Wu
    FRONTIERS IN MEDICINE, 2021, 8
  • [26] Expanded tumor-associated polymorphonuclear myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activity
    Bhardwaj, Vaishali
    Yang, Zhi-Zhang
    Jalali, Shahrzad
    Villasboas, Jose C.
    Mudappathi, Rekha
    Wang, Junwen
    Mukherjee, Prithviraj
    Paludo, Jonas
    Tang, Xinyi
    Kim, Hyo Jin
    Krull, Jordan E.
    Wenzl, Kerstin
    Novak, Anne J.
    Mondello, Patrizia
    Ansell, Stephen M.
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [27] Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts
    Maenhout, Sarah K.
    Van Lint, Sandra
    Emeagi, Perpetua U.
    Thielemans, Kris
    Aerts, Joeri L.
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (05) : 1077 - 1090
  • [28] The effects of TNF-α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer
    Qu, Yang
    Wang, Xianhao
    Bai, Shuai
    Niu, Liling
    Zhao, Gang
    Yao, Yuan
    Li, Bin
    Li, Hui
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (08) : 1373 - 1391
  • [29] Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery
    Su, Xiaosan
    Fan, Yaodong
    Yang, Liu
    Huang, Jie
    Qiao, Fei
    Fang, Yu
    Wang, Jun
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [30] Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid-derived suppressor cells via TLR2-dependent STAT3 activation
    Lee, Jung-Mi
    Kim, Eun-Kyung
    Seo, Hyungseok
    Jeon, Insu
    Chae, Min-Ji
    Park, Young-Jun
    Song, Boyeong
    Kim, Yun-Sun
    Kim, Yeon-Jeong
    Ko, Hyun-Jeong
    Kang, Chang-Yuil
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (06) : 1672 - 1684